How to implement the human readability study of single characters – application for biopharmaceutical vision system settings

Broadcast date

Thu, Oct 7, 2021

 

Presented by

    Steen Christiansen - Novo Nordisk

 

Quick Description

It is the authority’s expectation that any print is correct and readable for the patient. Therefore pharmaceutical companies must be able to document traceability between what patients can read and understand, and how much of a single character can be missing before correct interpretation is impaired.

Details

It is the authority’s expectation that any print is correct and readable for the patient. Therefore pharmaceutical companies must be able to document traceability between what patients can read and understand, and how much of a single character can be missing before correct interpretation is impaired.

Since the early 1990s, it has been common practice in pharmaceutical packaging that whenever batch-specific data is printed during the packaging process, the data is checked using vision systems. The BioPhorum Secondary Packaging Fill Finish workstream has prepared a study and report for human readability of single characters to provide supporting data to establish limit characters, i.e. what degree of print defect for a single character results in the character not being recognized properly by the human reader. This will serve as the basis for specific vision system settings which should reduce labeling errors. During the webinar attendees can expect an overview of the study followed by a discussion on how to implement and take value from the results. The presentation will end with Q&As with a panel of the study’s authors.

Speakers

Steen Christiansen

Principal Scientist – Packaging

Novo Nordisk